Evidence map›Paper›PMID 38380213›Full record

ReviewCureus2024

Behind the Mask: Parkinson's Disease and Depression.

Sneha Balasubramanian, Khawar Tariq Mehmood, Shahad Al-Baldawi, Gabriel Zúñiga Salazar, Diego Zúñiga

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Electroconvulsive therapy for Parkinson's disease-related apathy: A case report.PCN reports : psychiatry and clinical neurosciences · 2025
    Article
  2. [Research progress on repetitive transcranial magnetic stimulation for improving depression in Parkinson's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

Sneha BalasubramanianInternal Medicine, Madras Medical College, Chennai, IND.
Khawar Tariq MehmoodInternal Medicine, Aster Hospital Br of Aster DM Healthcare FZC, Dubai, ARE.
Shahad Al-BaldawiRheumatology, Al-Yarmouk Teaching Hospital, Baghdad, IRQ.
Gabriel Zúñiga SalazarMedicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, ECU.
Diego ZúñigaMedicine, Universidad Católica de Santiago de Guayaquil, Guayaquil, ECU.
Universidad Católica de Santiago de Guayaquil · ECAl Yarmouk University College · IQASTER · CAEast Central University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is a common, prevalent neurodegenerative disease. It is mainly characterized by motor symptoms such as rigidity, tremors, and bradykinesia, but it can also manifest with non-motor symptoms, of which depression is the most frequent. The latter can impair the quality of life, yet it gets overlooked and goes untreated because of the significant overlap in their clinical features, hence making the diagnosis difficult. Furthermore, there is limited data on the availability of appropriate criteria for making the diagnosis of depression in PD patients, as it can occur with varying expressions throughout the course of PD or it can also precede it. This review article has included a brief discussion on the diagnosis of depression in PD patients and their overlapped clinical manifestations. Understanding the mechanisms underlying the disease processes of PD and depression and the pathways interconnecting them gives better knowledge on devising treatment options for the patients. Only studies from Pubmed were included and all other databases were excluded. Studies from the last 50 years were included. Suitable references included in these studies were also extracted. Thus, depression in PD and PD in depression, along with their pharmacological and non-pharmacological treatment options, have been discussed.

Indexed as

anti-depressantscognitive behavioural therapydepressionelectro-convulsive therapyneurodegenerationneuropathologynon-motor symptomsparkinson' s diseasepimavanserintreatment of depression in parkinson's disease

Identifiers

PMID38380213
PMCPMC10877222
OpenAlexW4391060465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.